Basic Fluorouracil Information

• INN (International Nonproprietary Name): Fluorouracil (also known as 5‑Fluorouracil, 5‑FU).
• Brand Names Available In Canada (English): Efudex (topical listed for CAN); other brands and generics noted internationally include Adrucil, Fluoroplex, Carac, Actikerall and Tolak.
• ATC Code: L01BC02 (Antineoplastic agents; Antimetabolites; Pyrimidine analogues).
• Forms & Dosages: Injection vials commonly 250 mg/5 mL, 500 mg/10 mL and 1 g/20 mL; topical creams in 0.5%, 1%, 2%, 4% and 5% strengths in 20–40 g tubes.
• Manufacturers In Canada (English): not specified in the supplied product data.
• Registration Status In Canada (English): not specified in the supplied product data, though Efudex is listed as available in CAN in brand tables.
• OTC / Rx Classification: Prescription only (Rx); not available over‑the‑counter in any formulation.

Morning Vs Evening Dosing In Canadian Routines

Are you wondering whether to apply fluorouracil cream in the morning or at night?

Follow your prescriber’s exact regimen for 5‑FU routine and Efudex Canada instructions.

Topical creams such as Efudex or generics are typically applied once or twice daily for 2–6 weeks depending on the product and lesion.

Apply after your morning shower if your schedule allows and you plan to stay out of direct sun during the day.

Alternatively, apply before bedtime when the treated area can recover overnight and sun exposure is minimal.

Avoid applying topical 5‑FU immediately before sun exposure or tanning sessions because treated skin becomes fragile and photosensitive.

• Checklist: Apply thin layer to lesion, wash hands after application, avoid eyes and mouth, do not cover unless directed.

For injection regimens, schedule treatments around work or caregiving and confirm the exact dosing plan with your oncology team.

When IV 5‑FU causes nausea, try small, frequent Canadian‑style snacks such as plain toast, broth or ginger tea to reduce discomfort.

Avoid alcohol while skin is inflamed and warn partners that fluorouracil is teratogenic; use contraception as advised.

Taking With Or Without Meals (Canadian Diet Context)

Do food timings matter for topical versus systemic 5‑FU?

Topical fluorouracil cream has minimal systemic absorption, so no special meal timing is required when using Efudex or similar creams.

IV fluorouracil may cause nausea or mouth soreness, so bland, small meals reduce symptoms for many Canadians.

Foods such as plain crackers, toast, broth or ginger tea are often better tolerated than spicy or greasy dishes during IV cycles.

Avoid alcohol during treatment and while local skin reactions are present.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Who must not use fluorouracil?

Do not use fluorouracil if there is known hypersensitivity to 5‑FU or to any ingredient in the formulation.

Pregnancy is an absolute contraindication because fluorouracil is teratogenic.

Severe bone marrow suppression or active infection are absolute contraindications to systemic therapy.

Discuss DPYD testing with your prescriber before high‑dose IV 5‑FU because dihydropyrimidine dehydrogenase deficiency greatly increases toxicity risk.

• Contraindications: Known hypersensitivity; pregnancy (category D); severe bone marrow suppression; active infection.
• Relative cautions: Severe hepatic impairment; severe renal impairment; severe cardiac disease; poor nutritional status.

Activities To Limit (Driving, Workplace Safety)

What daily activities should you change while on 5‑FU?

Topical treatment can make skin fragile and sore, so avoid excessive sun and tanning beds until the area fully heals.

Wear protective clothing and broad‑spectrum sunscreen over untreated skin.

Driving or operating heavy machinery is usually safe with topical 5‑FU unless systemic side effects such as dizziness or fatigue occur.

IV 5‑FU can cause fatigue, nausea or cognitive effects; avoid unsafe activities when symptomatic.

• Checklist: Avoid tanning beds; limit direct sun; use sunscreen; request workplace accommodations for appointments or time off.

Ask your employer for short medical notes from your clinic to arrange appointment scheduling or temporary task changes.

Dosage & Adjustments

General Regimen (DIN References)

What are the common dosages for topical and injectable 5‑FU?

Topical formulations include strengths from 0.5% up to 5% and are applied once or twice daily for 2–6 weeks depending on the product and lesion location.

Examples include Efudex 2% and 5% in 20 g or 40 g tubes and Carac at 0.5% for some indications.

Injectable vials commonly found internationally include 250 mg/5 mL, 500 mg/10 mL and 1 g/20 mL; hospital pharmacies dispense these per oncology protocols.

One example systemic regimen from product data is 12 mg/kg/day IV bolus for 4 days (max 800 mg/day), then 6 mg/kg every other day for 6 doses (max 400 mg/day), recognising protocols vary.

Confirm the Drug Identification Number (DIN) on your prescription label and pharmacy receipt when arranging refills or reimbursement.

Special Cases (Elderly, Comorbidities)

Do older adults need lower doses?

Elderly patients usually do not require routine dose reduction but do need closer clinical and laboratory monitoring because of reduced organ reserve.

Renal and hepatic impairment may require dose reduction for systemic therapy because reduced clearance raises toxicity risk.

Patients with poor nutritional status, uncontrolled infection or severe organ dysfunction need specialist review and may require adjusted dosing and closer CBC and liver test monitoring.

DPYD deficiency testing should be considered when high‑dose IV regimens are planned to reduce risk of severe toxicity.

User Testimonials

Positive Reports From Canadian Patients

What do Canadians say about topical 5‑FU?

Many report effective clearance of actinic keratoses after a 2–6 week course of fluorouracil cream, praising the convenience of at‑home treatment compared with clinic procedures.

Patients often name local pharmacy chains such as Shoppers Drug Mart when discussing easy access to topical Efudex or generics.

IV 5‑FU recipients commonly describe manageable fatigue and temporary hair thinning during chemotherapy cycles and appreciate nursing support in oncology units.

• Pros: Effective for field therapy; lower immediate cost versus some clinic procedures; at‑home convenience.

Common Challenges In Forums (Reddit Canada, Health Boards)

What do online threads often complain about?

Patients report inconsistent instructions on application timing and confusion about provincial reimbursement and DIN coverage across Ontario Drug Benefit, BC PharmaCare and RAMQ.

Rural patients sometimes face delays obtaining topical formulations and may need orders from larger chains or specialty pharmacies.

Common treatment challenges include intense local skin reactions and questions about moisturizers and pain control during therapy.

• Checklist Of Questions To Bring To Your Clinician: Ask about expected severity of skin reaction, moisturiser recommendations, provincial coverage options, and DPYD testing if IV therapy is planned.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Where can Canadians get fluorouracil?

Topical fluorouracil creams such as Efudex and generics are commonly stocked by chain pharmacies including Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs.

Injectable vials are dispensed by hospital pharmacies or specialty oncology pharmacies rather than typical retail outlets.

Community pharmacies can often order topical products if they are not in stock; always check the DIN on the label to confirm the exact product.

Price Comparison (In‑Store Vs Online, Cross‑Border Notes)

How much will it cost and what about online options?

Out‑of‑pocket cost varies by strength, tube size and provincial coverage criteria; provincial plans such as Ontario Drug Benefit and BC PharmaCare may cover some indications depending on formulary rules.

In our online pharmacy, fluorouracil is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

Ask your pharmacist about generic options, patient assistance programs or provincial formulary processes if cost is a concern.

What’s Inside & How It Works

Ingredients Overview

What is in a tube or vial of fluorouracil?

The active ingredient in topical and injectable products is fluorouracil (5‑FU).

Topical creams contain 0.5–5% 5‑FU in a cream vehicle with excipients and preservatives that vary by brand; check the product leaflet for full excipient lists for Efudex, Fluoroplex or Carac.

Injectable vials contain concentrated 5‑FU for dilution and administration under hospital protocols; common vial sizes are 250 mg/5 mL, 500 mg/10 mL and 1 g/20 mL.

• Topical: Active = fluorouracil 0.5–5% plus vehicle excipients.
• Injection: Active = fluorouracil concentrate for IV use, vial sizes per above.

Mechanism Basics

How does fluorouracil work against skin lesions and cancer?

Fluorouracil is a pyrimidine analogue that interferes with DNA synthesis in rapidly dividing cells.

Topically applied 5‑FU preferentially affects abnormal keratinocytes such as actinic keratoses and superficial basal cell carcinoma cells, causing inflammation and eventual lesion sloughing.

Systemic IV 5‑FU targets dividing cancer cells but can also affect bone marrow and the gastrointestinal lining, which explains common systemic side effects.

Main Indications

Approved Uses In Canada

What is fluorouracil approved to treat?

Topical fluorouracil is used for actinic keratosis and superficial basal cell carcinoma in dermatology practice.

Systemic IV fluorouracil is an antineoplastic agent used in colorectal, gastric and breast cancer regimens per oncology protocols.

Topical concentrations commonly used include 0.5%, 1%, 2%, 4% and 5% for 2–6 week courses depending on the formulation and lesion.

Off‑Label Uses By Canadian Physicians

When might clinicians use 5‑FU off‑label?

Dermatologists sometimes adapt concentrations or application schedules for field therapy of diffuse actinic damage or combine 5‑FU with other topical agents for enhanced clearance.

Oncologists commonly use 5‑FU in combination with leucovorin or substitute with capecitabine (an oral prodrug) in some regimens.

Off‑label uses should be explained and documented by the prescriber and may not be covered by provincial formularies.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Do diet and drinks interact with 5‑FU?

Topical fluorouracil has minimal systemic absorption and requires no specific food restrictions beyond sun avoidance.

During IV therapy, avoid excessive alcohol because it can worsen mucositis and place extra strain on the liver.

Caffeine has no major interaction with 5‑FU, but fatigue and sleep changes during chemotherapy may change consumption habits.

Small bland meals are often better tolerated when nausea is present.

Drug Conflicts (Health Canada Database)

Which medicines should you flag to your pharmacist?

Fluorouracil can potentiate warfarin, increasing INR and bleeding risk; tell your pharmacist if you take warfarin or other anticoagulants.

Concurrent use with allopurinol or certain antibiotics such as metronidazole may increase 5‑FU toxicity.

Medications or conditions that reduce DPD enzyme activity can greatly increase 5‑FU toxicity; discuss DPYD testing before high‑dose intravenous therapy.

• Checklist To Tell Your Pharmacist: Warfarin; allopurinol; metronidazole; OTCs and herbal products such as St. John’s wort; supplements.

Latest Evidence & Insights

Highlight Canadian And International Research (Tables Recommended)

What does recent research emphasise about 5‑FU?

Fluorouracil is a World Health Organization essential medicine and remains a core pyrimidine analogue in oncology (ATC L01BC02).

Topical 5‑FU is supported by Canadian and international studies as effective for field therapy of actinic keratosis, with clearance rates influenced by concentration and duration.

Recent practice trends increasingly recommend DPYD pharmacogenomic screening before high‑dose IV therapy to reduce severe toxicity, with several European programmes already adopting routine testing and Canadian centres discussing it pre‑treatment.

Practical Takeaways For Patients

What should patients remember from recent evidence?

Expect a predictable inflammatory response with topical 5‑FU and follow prescriber directions for duration and skin care.

If starting IV 5‑FU, ask about DPYD testing, an antiemetic plan and the schedule for blood monitoring.

Confirm DINs when arranging refills and check provincial formularies for coverage before purchase.

Alternative Choices

List Of Comparable Medicines With Pros/Cons Checklist

What are common alternatives to fluorouracil?

Topical alternatives for actinic keratoses and superficial BCC include imiquimod, diclofenac gel, photodynamic therapy (PDT) and cryotherapy.

Systemic alternatives in oncology include capecitabine (an oral prodrug of 5‑FU), gemcitabine and tegafur combinations.

• Pros/Cons Checklist: Capecitabine—oral convenience but similar toxicity profile and requires strict adherence.
• Imiquimod—may cause less acute inflammation for some patients but clearance can vary.
• PDT—clinic‑based, effective for field therapy with a different side‑effect profile.
• Cryotherapy—rapid treatment for individual lesions rather than field disease.

When To Discuss Switching With Your Clinician

When should you ask about a different option?

Consider switching when there is inadequate response after the prescribed course, intolerable side effects, pregnancy plans or access and cost concerns.

For systemic therapy, switching requires oncologist oversight and may involve different monitoring schedules and supportive care.

Regulation Snapshot

Health Canada Approval And DIN Requirements

What regulatory checks should you do when getting 5‑FU?

Fluorouracil formulations are prescription‑only in Canada and marketed products carry Drug Identification Numbers (DINs) that identify the exact product for dispensing and reimbursement.

Check the DIN on the label to verify the formulation and for provincial reimbursement claims.

Health Canada product monographs and Notice of Compliance records provide safety and usage details for approved products.

Provincial Coverage And Prescribing Norms

How does coverage vary across Canada?

Reimbursement varies by province; Ontario Drug Benefit, BC PharmaCare and RAMQ have differing criteria for coverage depending on indication and formulary listings.

Topical creams may be covered for specific dermatologic indications and may require prior authorizations or documentation from specialists.

Pharmacists routinely verify DINs, counsel on application and storage, and can coordinate special orders or refills.

FAQ Section

Will Topical 5‑FU Make My Skin Worse Before It Gets Better?

Yes, expect redness, crusting and flaking as the drug targets abnormal cells; this is a normal response while treating actinic keratoses.

Use gentle, fragrance‑free moisturizers and avoid sun exposure during and after treatment.

Contact your clinic if you develop severe pain, spreading infection, fever or systemic symptoms.

Can I Get Fluorouracil Without A Provincial Drug Plan Covering It?

Yes, topical and injectable fluorouracil are available by prescription from licensed Canadian pharmacies or hospital pharmacies, but you will pay out‑of‑pocket unless provincial coverage or private insurance applies.

Ask your pharmacist about generic alternatives, manufacturer patient assistance programs, or clinic‑administered options that may reduce direct costs.

• Additional FAQ: DPYD Testing — Ask your prescriber if pharmacogenomic testing for DPD deficiency is recommended before high‑dose IV therapy.
• Additional FAQ: Pregnancy — Fluorouracil is teratogenic; discuss contraception and timing with your specialist.
• Additional FAQ: Storage — Store topical creams below 25°C and injection vials at 20–25°C, protected from light.

When To Call Your Clinic: fever, severe diarrhoea, uncontrolled vomiting, bleeding, breathing difficulty, or rapid spread of skin reaction.

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

What counselling should pharmacists provide?

Pharmacists should verify prescription, DIN and indication and counsel on application technique for topical creams.

For topical 5‑FU counsel to apply a thin layer only to affected skin, avoid normal surrounding skin, and wash hands after application unless the hands are the treatment site.

Advise storage below 25°C for topical creams and 20–25°C for injectable vials and instruct patients to protect vials from light.

Follow‑Up, Monitoring And When To Seek Help

What monitoring is required?

For topical therapy, arrange dermatology follow‑up at the end of the prescribed course to assess lesion clearance and scarring.

For systemic IV therapy, oncology teams schedule regular laboratory monitoring including CBC, liver function tests and creatinine prior to and during cycles.

Seek immediate medical attention for fever, severe diarrhoea, uncontrolled vomiting, bleeding, or signs of severe skin reaction such as widespread blistering or mucosal involvement.

Delivery Across Canada (English)